17159-80-7

Basic information

• Product Name: ETHYL 4-HYDROXYCYCLOHEXANECARBOXYLATE
• Synonyms: Ethyl 4-hydroxycyclohexanecarboxylate, mixture of cis and trans ,98%;ethyl 4-hydroxycyclohexane-1-carboxylate;Ethyl 4-hydroxycyclohexylcarboxylate;Ethyl 4-hydroxycyclohexanecarboxylate, Mixture of cis and trans 98%;Ethyl 4-hydroxycyclohexanecarbonate;Ethyl 4-hydroxycyclohexanecarboxylate≥ 99% (assay);ETHYL 4-HYDROXYCYCLOHEXANECARBOXYLATE;Ethyl 4-hydroxycyclohexanecarboxylate,mixture of cis and trans
• CAS NO: 17159-80-7
• Molecular Formula: C₉H₁₆O₃
• Molecular Weight: 172.22
• EINECS: 241-215-1
• Product Categories: C8 to C9;Carbonyl Compounds;Esters
• Mol File: 17159-80-7.mol
• Article Data: 19

Chemical Properties

• Boiling Point: 127-134 °C0.1 mm Hg(lit.)
• Flash Point: >230 °F
• Appearance: /
• Density: 1.068 g/mL at 25 °C(lit.)
• Vapor Pressure: 0.00322mmHg at 25°C
• Refractive Index: n20/D 1.466(lit.)
• Storage Temp.: Keep in dark place,Sealed in dry,Room Temperature
• PKA: 14.98±0.40(Predicted)
• Water Solubility: Not miscible or difficult to mix in water.
• CAS DataBase Reference: ETHYL 4-HYDROXYCYCLOHEXANECARBOXYLATE(CAS DataBase Reference)
• NIST Chemistry Reference: ETHYL 4-HYDROXYCYCLOHEXANECARBOXYLATE(17159-80-7)
• EPA Substance Registry System: ETHYL 4-HYDROXYCYCLOHEXANECARBOXYLATE(17159-80-7)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38
• Safety Statements: 26-36
• WGK Germany: 3
• Hazardous Substances Data: 17159-80-7(Hazardous Substances Data)

Usage

Description

ETHYL 4-HYDROXYCYCLOHEXANECARBOXYLATE, also known as Ethyl 4-hydroxycyclohexanecarboxylate (cis + trans), is an organic compound that serves as a crucial intermediate in the synthesis of various chemicals and pharmaceuticals. Its unique chemical structure allows it to be a versatile building block in the creation of different compounds.

Uses

Used in Chemical Synthesis:
ETHYL 4-HYDROXYCYCLOHEXANECARBOXYLATE is used as a chemical intermediate for the synthesis of other chemicals. It plays a vital role in the production of various compounds due to its reactive functional groups and compatibility with a wide range of chemical reactions.
Used in Pharmaceutical Industry:
ETHYL 4-HYDROXYCYCLOHEXANECARBOXYLATE is used as a pharmaceutical intermediate for the development of new drugs and medications. Its unique structure and reactivity make it an essential component in the synthesis of various pharmaceutical compounds, contributing to the advancement of medical treatments and therapies.

Synthesis Reference(s)

The Journal of Organic Chemistry, 30, p. 4145, 1965 DOI: 10.1021/jo01023a039

InChI:InChI=1/C9H16O3/c1-2-12-9(11)7-3-5-8(10)6-4-7/h7-8,10H,2-6H2,1H3

Upstream product

• 120-47-8 Ethyl 4-hydroxybenzoate 
• 17159-79-4 ethyl 4-oxocyclohexane-1-carboxylate 
• 64-17-5 ethanol 
• 3685-22-1 4-hydroxycyclohexanecarboxylic acid 
• 99-96-7 4-hydroxy-benzoic acid 
• 3685-26-5 trans-4-hydroxycyclohexanecarboxylic acid 
• 123-91-1 1,4-dioxane 

Downstream Products

• 53287-45-9 4-chloro-1-cyclohexanecarboxylic acid chloride 
• 3685-27-6 (1r,4r)-4-(hydroxymethyl)cyclohexanol 
• 3685-24-3 1r-Hydroxymethyl-cyclohexanol-(4c) 
• 17159-79-4 ethyl 4-oxocyclohexane-1-carboxylate 
• 3685-26-5 trans-4-hydroxycyclohexanecarboxylic acid 
• 15580-00-4 1-Phenylsulfon-2-oxo-2-(4-hydroxy-cyclohexyl)ethan 
• 1221724-30-6 4-hydroxycyclohexane-1-carboxamide 
• 676560-15-9 Ethyl (cis/trans)-4-<(tert-butyldimethylsilyl)oxy>cyclohexanecarboxylate 
• 17328-67-5 4-(2-hydroxypropan-2-yl)cyclohexanone 
• 223699-80-7 cis-pentamethylbenzyl 4-hydroxycyclohexanecarboxylate 
• 3685-22-1 4-hydroxycyclohexanecarboxylic acid 
• 923-42-2 butane-1,2,4-tricarboxylic acid 
• 888970-51-2 4-fluoro-cyclohexanecarboxylic acid pentamethylphenylmethyl ester 
• 223699-83-0 trans-pentamethylbenzyl 4-fluorocyclohexanecarboxylate 

Relevant articles and documents

HETEROARYLDIHYDROPYRIMIDINE DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS

Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.

A biocatalytic/reductive etherification approach to substituted piperidinyl ethers

A synthetically useful protocol has been developed for the preparation of highly functionalized piperidinyl ethers. Biocatalytic reduction of cyclhexanones 7, 10, and 14 allows for the preparation of both cis- and trans diastereomers with an extremely high degree of stereochemical control. Reductive etherification of the corresponding trimethylsilylethers with 1-(benzyloxycarbonyl)-4-piperidinone 17 in the presence of triethylsilane and catalytic TMSO-Tf provides the desired piperidinyl ethers in good to excellent yields. Finally hygrogenolysis of the nitrogen protecting group leads to piperidinyl ethers in near quantitative yields. Application of the methodology to a range of piperidinyl ethers, including the core scaffolds of diphenylpyraline and ebastine, is also described.

IMIDAZOLE DERIVATIVES

Described herein are compounds of formula (I), The compounds of formula I act as DGAT1 inhibitors and can be useful in preventing, treating or acting as a remedial agent for hyperlipidemia, diabetes mellitus and obesity.